25th Amendment Removal Market Analysis

Current Odds

Platform	Yes	No	Volume	Trade
Polymarket	11.0%	89.0%	$10K	Trade on Polymarket

Market Analysis

Current pricing at 11% reflects genuine constitutional uncertainty but also substantial structural barriers to removal. This market matters because the 25th Amendment represents the only mechanism to remove a sitting president without impeachment conviction, yet it remains untested in modern politics and requires extraordinary conditions: a president deemed unfit by their cabinet, a supermajority congressional vote, and sustained political will across party lines. Given Trump’s current political control over the Republican Party and cabinet composition, the odds appropriately discount this as a tail-risk scenario rather than a serious near-term threat.

The bull case for removal rests on potential catastrophic health events or documented cognitive decline severe enough to compel cabinet action despite Trump’s control over appointments. The 25th Amendment’s Section 4 requires only a cabinet majority to invoke removal, and even hostile cabinet members could theoretically act if Trump suffered a major stroke, dementia diagnosis, or similar medical event that transcended partisan boundaries. Historical precedent exists—Reagan’s cabinet managed succession around his declining cognition in his second term—and if major news organizations and medical professionals began openly questioning fitness, social pressure could mount on appointees. The 2025 congressional calendar offers no natural inflection points, but any health crisis, major military incident with questionable decision-making, or documented psychiatric event could rapidly shift market probability. The market’s 11% pricing acknowledges this genuine tail risk rather than dismissing it entirely.

The bear case dominates reality: Trump controls Republican appointments, has historically appointed loyalists to cabinet positions, and the party structure provides near-total protection from removal. Section 4 of the 25th Amendment requires two-thirds congressional supermajorities (290 House votes, 67 Senate votes) to override a presidential declaration that he remains fit—a threshold Trump’s current party control easily defeats. No cabinet secretary would initiate removal against a president who appointed them without overwhelming medical/psychiatric evidence, and Trump’s known resistance to medical documentation makes formal diagnosis unlikely. The market’s 11% reflects appropriate probability assigned to an extremely low-likelihood scenario given current political alignment; reaching 25%+ would require either a change in party control or Trump voluntarily stepping aside.

Key catalysts to monitor include any major health incidents, significant cognitive lapses captured on video, or unexpected cabinet turnover that might replace loyalists with potential skeptics. The primary calendar runs through mid-2024, with general election in November 2024 and potential cabinet confirmation battles in late 2024/early 2025. Traders should watch for any major medical events, unexpected departures from the cabinet, or shifts in Republican congressional willingness to constrain executive power. The 2-3 year expiry means this remains a true long-tail bet rather than a near-term outcome, and the current 11% pricing appears appropriately calibrated to the actual constitutional, political, and medical barriers involved.

Related Markets

• Will JD Vance win the 2028 US Presidential Election? — 18% YES
• Will Pete Buttigieg win the 2028 Democratic presidential nomination? — 4% YES
• Will Amanda Anisimova be the 2026 Women’s Wimbledon Winner? — 5% YES

Frequently Asked Questions

What specific medical conditions or events would make 25th Amendment removal plausible rather than theoretical?

A major stroke, documented dementia diagnosis, or severe psychiatric break with public medical evidence could force cabinet action, though even then Republican congressional supermajorities would likely protect Trump from the two-thirds override needed if he contests removal.

Why doesn’t Trump’s complete control over his cabinet make this market trade at 2-3% instead of 11%?

The 11% premium accounts for genuine tail risks including unexpected health crises, potential cabinet turnover if Trump appoints less-loyal figures, and the non-zero probability that medical reality could override political loyalty in extreme scenarios.